Page last updated: 2024-09-03

parecoxib and Disease Models, Animal

parecoxib has been researched along with Disease Models, Animal in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (36.00)29.6817
2010's13 (52.00)24.3611
2020's3 (12.00)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Chen, Q; Guo, Y; Min, S; Wu, B1
Chai, X; Hu, S; Shu, S; Wang, D; Wei, X; Zhang, C; Zosky, GR1
Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A1
Belguise, K; Chen, B; Chen, L; Gao, J; Liu, C; Lu, K; Wang, X; Yi, B; Yu, W1
Bakar, B; Budak Yildiran, FA; Dincel, GC; Kisa, U; Ogden, M; Yuksel, U1
Chen, Z; Li, J; Shi, J; Wang, YB1
Arung, W; Cheramy, JP; Defraigne, JO; Detry, O; Drion, P; Honoré, P; Jehaes, F; Meurisse, M1
Cui, W; Yu, X; Zhang, H1
Barros, GA; Calistro Neto, JP; Domingues, MA; Gonçalves, GM; Módolo, NS; Silva, LM; Torres, Rda C1
Huang, WQ; Ma, Y; Xu, KQ; Zhang, T1
Babis, GC; Korres, DS; Nikolopoulos, K; Soucacos, PN; Tsailas, PG1
Herschman, HR; Ishikawa, TO; Jain, NK; Spigelman, I1
Acencio, MM; Antonangelo, L; Costa, JD; Marchi, E; Novaes, NP; Teixeira, LR; Vargas, FS1
Abbate, A; Hoke, NN; Houser, JE; Ownby, ED; Salloum, FN; Seropian, IM; Van Tassell, BW; Varma, A1
Abrao, MS; Alves, LM; Berardo, PT; Fernandes, PD; Landgraf, RG; Machado, DE; Nasciutti, LE; Palmero, C1
Bavbek, M; Bilginer, B; Çelik, Ö; Gürgör, PN; Korkmaz, A; Özgen, T; Ziyal, İ1
Armstrong, PC; Emerson, M; Kirkby, NS; Mitchell, JA; Warner, TD; Zain, ZN1
Badn, W; Darabi, A; Eberstål, S; Esbjörnsson, M; Fritzell, S; Siesjö, P; Visse, E1
Becker, A; Geisslinger, G; Grecksch, G; Höllt, V; Murín, R; Schröder, H; Zimmer, A1
Bloemendaal, AL; Borel Rinkes, IH; Kranenburg, O; Smakman, N; van Diest, P; Vogten, JM1
Kulkarni, SK; Padi, SS1
Coelho, AM; da Cunha, JE; de Almeida, JL; Jukemura, J; Machado, MC; Patzina, RA1
Abbate, A; Baldi, A; Biasucci, LM; Biondi-Zoccai, GG; Crea, F; Fowler, AA; Kukreja, RC; Lipinski, MJ; Ockaili, RA; Salloum, FN; Straino, S; Vetrovec, GW1
Kamerman, P; Koller, A; Loram, L1

Other Studies

25 other study(ies) available for parecoxib and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Parecoxib ameliorates renal toxicity and injury in sepsis-induced mouse model and LPS-induced HK-2 cells.
    Drug development research, 2022, Volume: 83, Issue:3

    Topics: Acute Kidney Injury; Animals; Apoptosis; Cyclooxygenase 2; Disease Models, Animal; I-kappa B Kinase; Inflammation; Isoxazoles; Lipopolysaccharides; Mice; NF-kappa B; Sepsis

2022
Paracoxib Alleviates Ventilator-Induced Lung Injury Through Functional Modulation of Lung-Recruited CD11bloLy6Chi Monocytes.
    Shock (Augusta, Ga.), 2021, 02-01, Volume: 55, Issue:2

    Topics: Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Isoxazoles; Lung; Male; Mice; Mice, Inbred C57BL; Monocytes; Ventilator-Induced Lung Injury

2021
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.
    British journal of pharmacology, 2017, Volume: 174, Issue:16

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography

2017
Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
    Biochemical pharmacology, 2017, 08-15, Volume: 138

    Topics: Animals; Bone Morphogenetic Protein 2; Carrier Proteins; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endothelium, Vascular; Hepatopulmonary Syndrome; Injections, Intraperitoneal; Injections, Intravenous; Isoxazoles; Lung; Macrophage Activation; Macrophages, Alveolar; Microvessels; Neovascularization, Pathologic; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction

2017
The Investigation of the Cox-2 Selective Inhibitor Parecoxib Effects in Spinal Cord Injury in Rat.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2019, Volume: 32, Issue:5

    Topics: Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Humans; Injections, Intraperitoneal; Isoxazoles; Laminectomy; Male; Methylprednisolone; Rats; Spinal Cord; Spinal Cord Injuries; Treatment Outcome

2019
Parecoxib improves the cognitive function of POCD rats via attenuating COX-2.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:11

    Topics: Animals; Apoptosis; Cognition; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Hippocampus; Humans; Isoxazoles; Male; Neurons; Postoperative Cognitive Complications; Rats; Up-Regulation

2019
Effects of parecoxib on the prevention of postoperative peritoneal adhesions in rats.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2013, Volume: 26, Issue:6

    Topics: Anastomosis, Surgical; Animals; Burns, Electric; Cecum; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Injections, Intramuscular; Isoxazoles; Male; Peritoneal Diseases; Plasminogen Activator Inhibitor 1; Postoperative Complications; Rats; Rats, Sprague-Dawley; Tissue Adhesions; Tissue Plasminogen Activator; Wound Healing

2013
The Study of Different Approaches of Parecoxib Sodium Pretreatment on the Behavior of Rats with Neuropathic Pain.
    Cell biochemistry and biophysics, 2015, Volume: 72, Issue:1

    Topics: Analgesics; Animals; Disease Models, Animal; Drug Administration Schedule; Hot Temperature; Inflammation; Injections, Intraperitoneal; Injections, Spinal; Isoxazoles; Male; Neuralgia; Pain Management; Pain Measurement; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Nerves

2015
Parecoxib reduces renal injury in an ischemia/reperfusion model in rats.
    Acta cirurgica brasileira, 2015, Volume: 30, Issue:4

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Blood Pressure; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Isoxazoles; Kidney; Lipocalin-2; Lipocalins; Male; Prospective Studies; Proto-Oncogene Proteins; Random Allocation; Rats, Wistar; Reperfusion Injury; Reproducibility of Results; Severity of Illness Index; Time Factors; Treatment Outcome

2015
Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats.
    BMC anesthesiology, 2015, Nov-17, Volume: 15

    Topics: Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Isoxazoles; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2015
The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits.
    The Journal of surgical research, 2009, Volume: 151, Issue:1

    Topics: Animals; Bone and Bones; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Indomethacin; Injections, Subcutaneous; Isoxazoles; Male; Meloxicam; Ossification, Heterotopic; Osteogenesis; Rabbits; Radiography; Thiazines; Thiazoles

2009
COX-2 expression and function in the hyperalgesic response to paw inflammation in mice.
    Prostaglandins, leukotrienes, and essential fatty acids, 2008, Volume: 79, Issue:6

    Topics: Animals; Blotting, Western; Brain; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Gene Expression Regulation, Enzymologic; Hindlimb; Hyperalgesia; Inflammation; Isoxazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Zymosan

2008
Influence of parecoxib (cox-2 inhibitor) in experimental pleurodesis.
    Respiratory medicine, 2009, Volume: 103, Issue:4

    Topics: Animals; Biomarkers; Brazil; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Isoxazoles; Lung; Pleura; Pleural Diseases; Pleurodesis; Rabbits; Random Allocation; Silver Nitrate; Talc

2009
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6

    Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling

2009
A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
    Fertility and sterility, 2010, May-15, Volume: 93, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endometriosis; Female; Isoxazoles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2010
Effects of intramuscular parecoxib administration on vasospasm in an experimental subarachnoid hemorrhage model.
    The International journal of neuroscience, 2011, Volume: 121, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Injections, Intramuscular; Isoxazoles; Male; Rabbits; Random Allocation; Subarachnoid Hemorrhage; Vasospasm, Intracranial

2011
Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse.
    PloS one, 2011, Volume: 6, Issue:5

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Collagen; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Isoxazoles; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Thrombosis

2011
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
    Cancer immunology, immunotherapy : CII, 2012, Volume: 61, Issue:8

    Topics: Animals; Brain Neoplasms; Combined Modality Therapy; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Flow Cytometry; Glioblastoma; Immunohistochemistry; Immunotherapy, Adoptive; Interferon-gamma; Isoxazoles; Male; Neoplasms, Experimental; Rats; Rats, Inbred F344

2012
Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:5

    Topics: Animals; Cannabinoids; Chronic Disease; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cannabinoid, CB1; Sciatic Neuropathy; Species Specificity; Treatment Outcome

2013
Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-01, Volume: 11, Issue:1

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Genes, ras; Image Processing, Computer-Assisted; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Microcirculation; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins p21(ras); RNA Interference; Time Factors

2005
Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
    Indian journal of experimental biology, 2005, Volume: 43, Issue:1

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Disease Models, Animal; Female; Hyperalgesia; Isoenzymes; Isoxazoles; Ketorolac; Lipopolysaccharides; Male; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Salmonella typhimurium

2005
Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis.
    Clinics (Sao Paulo, Brazil), 2006, Volume: 61, Issue:4

    Topics: Acute Disease; Amylases; Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Interleukin-10; Interleukin-6; Isoxazoles; Male; Pancreatitis; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid

2006
Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:6

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Heart Failure; Heart Function Tests; Isoxazoles; Male; Myocardial Ischemia; Myocardium; Rats; Rats, Wistar

2007
Postoperative administration of the analgesic tramadol, but not the selective cyclooxygenase-2 inhibitor parecoxib, abolishes postoperative hyperalgesia in a new model of postoperative pain in rats.
    Pharmacology, 2007, Volume: 80, Issue:4

    Topics: Analgesics, Opioid; Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Hyperalgesia; Isoxazoles; Pain, Postoperative; Rats; Rats, Sprague-Dawley; Tramadol

2007